ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties
about
Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell MigrationDecellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interactionThe potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosisGrowth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive graspingGpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C DiseaseGenomic analysis of wig-1 pathwaysTargeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashionRole of microRNA-150 and glycoprotein nonmetastatic melanoma protein B in angiogenesis during hyperoxia-induced neonatal lung injuryGranulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastasesADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor proteinOncogenic properties of apoptotic tumor cells in aggressive B cell lymphomaGlycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse modelsClaudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytesBeneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitisIdentification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure.SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasisChordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and InvasionPhase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells.Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis modelIntra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration.Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signalingExpression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult ratsGPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response.
P2860
Q26777586-CBB60D4F-561D-4230-A469-9F32BAAD3CF8Q27333526-B9591F32-3992-4FB2-B539-ADB18E181D65Q28117892-5B93B755-8C59-4672-B782-2E43C3C39EEBQ28384478-40F8489E-6C5A-45DE-849A-1EB6736FA45CQ28552531-F228C339-8A97-417B-86C2-49FF356A9944Q28732207-6912C22F-D32A-4F72-9AEC-EA6BD7BD46E7Q34247178-BCAE5F69-5173-43D5-A723-16180C73106FQ34389108-0FF7E3AA-9383-4342-9AA1-37F218C78C8FQ35207648-B88DD275-2177-411E-9747-521C47DF1960Q35549911-9842A454-F7F6-44E6-A3F2-4A6423105E92Q35562470-07385A49-A5BC-4ED6-8CF7-03A5A77AB5B4Q35565000-A373E5AD-7308-463C-B7DF-AEAA43BDCF4DQ35961610-FDB8361E-E413-4E2C-952B-8BB463F4453EQ36051772-3FA238CB-1F77-41BF-9106-C0602A14174CQ36136923-9553F4CF-97B8-4830-8C90-05EDE6B4EDD0Q36210944-24F63125-4EF4-4FBB-9846-FA751FDEBBE0Q36298216-7263C0DE-8DC6-4309-8BE5-A392768F3B04Q36320733-E28D8372-E810-419C-8EC3-27436924E444Q36329547-57FE18F6-C9EC-4D65-A1F9-A7AF3807AE89Q36503385-37B87013-0954-41CF-8804-8AA5D2A97A2BQ36620907-5FDAB397-DEB9-4C50-A00D-AEA11EE0EE5EQ36878808-2311F92E-FFA8-41C1-ABE5-16FCC29D146BQ36934332-C6EF6E73-625B-423E-AF9B-76F40218702BQ36961713-0B74D483-C5FA-4843-B6F7-3A87E4154E2CQ36967843-541D8129-4EFB-40F0-9F6E-C8EAE5A4B8C5Q37014479-2915C6E0-9A0C-4E29-9577-7F5FE75E0286Q37046492-31BA7AA7-F11E-40A2-9B16-4877427617BFQ37148134-39F8FFED-7349-4679-957E-AE52AF402DABQ37193373-4F39CDFB-7EB6-4821-8920-E97EFC54E68AQ37603941-1C4ED4F4-5B3B-4142-9BFC-6D53CED711D1Q38185304-114F872B-9B7B-430F-AFC5-EF8DD1FC5C3DQ38654361-35317CDA-2914-4570-808C-A9A9CA891A68Q38814412-920426D3-F3C0-4A14-87F1-F01DF7CA93FFQ38895095-38E080DB-A951-4C76-94B1-99B1902F8F63Q38899852-D94AC94B-FA14-464F-9329-905A860B6E90Q38911571-281F6482-8F79-44B6-942C-9319A3583041Q39000232-4E4E2B98-276F-4465-BD59-EDA02D9C5B8DQ39431450-B9C0A4B1-F8E0-461F-88B9-D97D6D177882Q42002720-221B8726-8A32-4A87-AFD1-795E28E7E083Q42362892-EF79E44B-5B1D-44FD-A135-5913ECAF8FE9
P2860
ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
ADAM10 releases a soluble form ...... ain with angiogenic properties
@ast
ADAM10 releases a soluble form ...... ain with angiogenic properties
@en
ADAM10 releases a soluble form ...... ain with angiogenic properties
@nl
type
label
ADAM10 releases a soluble form ...... ain with angiogenic properties
@ast
ADAM10 releases a soluble form ...... ain with angiogenic properties
@en
ADAM10 releases a soluble form ...... ain with angiogenic properties
@nl
prefLabel
ADAM10 releases a soluble form ...... ain with angiogenic properties
@ast
ADAM10 releases a soluble form ...... ain with angiogenic properties
@en
ADAM10 releases a soluble form ...... ain with angiogenic properties
@nl
P2093
P2860
P921
P3181
P1433
P1476
ADAM10 releases a soluble form ...... ain with angiogenic properties
@en
P2093
April A N Rose
Francois Pepin
Matthew G Annis
Michael Hallett
Morag Park
Peter M Siegel
Zhifeng Dong
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0012093
P407
P577
2010-01-01T00:00:00Z